RetractedArticleDrug design, development and therapy2015

A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation.

Jingde Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.